Two Whole-Time Directors resign from Bliss GVS Pharma

Multiple Ind Directors ResignedKmp ResignedManagement Changes View source PDF Explain this filing

BLISSGVS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.9%Reaction day

₹204.50

prior close

₹208.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.5%+5.4% vs market

Pharmaceuticals peers, median of 159sector-0.0%+4.9% vs sector

On the reaction day the stock moved 5.4 pts more than Nifty Microcap 250 and 4.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.1

10m

-0.7

15m

-0.1

30m

+1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.9-0.5+5.4-0.0+4.9

Next day

+6.6-1.0+7.6-0.2+6.7

+5.6-2.5+8.1-1.9+7.5

+8.1-3.2+11.2-2.4+10.5

+13.1-2.2+15.4-2.2+15.4

+12.4-1.9+14.3-1.9+14.3

+9.3-3.5+12.8-2.9+12.3

15d

+5.8-8.8+14.6-6.7+12.5

+5.8-9.3+15.1-6.7+12.5

+27.6-4.5+32.2-3.7+31.3

+33.5+5.4+28.1+2.9+30.6

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Bliss GVS Pharma announced that two Whole-Time Directors, Mrs Shruti Vishal Rao and Dr Vibha Gagan Sharma, have resigned effective February 10, 2026 due to other professional commitments. Both are daughters of the company's Managing Director and CEO, Mr Narsimha Shibroor Kamath. The board accepted the resignations the same day. They will also step down from board committees.

Likely market impact

Two promoter-family Whole-Time Directors exit the board on the same day. The Managing Director and CEO remains. May raise governance and succession questions.